dalteparin has been researched along with Celiac Disease in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Celiac Disease: A malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babanova, AV | 1 |
| Krums, LM | 1 |
| Bykova, SV | 1 |
| Parfenov, AI | 1 |
| Dudina, GA | 1 |
| Sabelnikova, EA | 1 |
| Khomeriki, SG | 1 |
| Lesko, KA | 1 |
| Dbar, SR | 1 |
1 other study available for dalteparin and Celiac Disease
| Article | Year |
|---|---|
[Celiac crisis in patients with celiac disease. Case report].
Topics: Adult; Anti-Bacterial Agents; Atrophy; Celiac Disease; Child; Diet, Gluten-Free; Female; Humans; Mid | 2021 |